{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T09:57:55Z","timestamp":1778839075416,"version":"3.51.4"},"reference-count":30,"publisher":"FapUNIFESP (SciELO)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An. Acad. Bras. Ci\u00eanc."],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:p>Vaccination is the most practical and cost-effective strategy to prevent the majority of the flavivirus infection to which there is an available vaccine. However, vaccines based on attenuated virus can potentially promote collateral side effects and even rare fatal reactions. Given this scenario, the developent of alternative vaccination strategies such as DNA-based vaccines encoding specific flavivirus sequences are being considered. Endogenous cytoplasmic antigens, characteristically plasmid DNA-vaccine encoded, are mainly presented to the immune system through Major Histocompatibility Complex class I - MHC I molecules. The MHC I presentation via is mostly associated with a cellular cytotoxic response and often do not elicit a satisfactory humoral response. One of the main strategies to target DNA-encoded antigens to the MHC II compartment is expressing the antigen within the Lysosome-Associated Membrane Protein (LAMP). The flavivirus envelope protein is recognized as the major virus surface protein and the main target for neutralizing antibodies. Different groups have demonstrated that co-expression of flavivirus membrane and envelope proteins in mammalian cells, fused with the carboxyl-terminal of LAMP, is able to induce satisfactory levels of neutralizing antibodies. Here we reviewed the use of the envelope flavivirus protein co-expression strategy as LAMP chimeras with the aim of developing DNA vaccines for dengue, West Nile and yellow fever viruses.<\/jats:p>","DOI":"10.1590\/s0001-37652009000400005","type":"journal-article","created":{"date-parts":[[2009,11,5]],"date-time":"2009-11-05T06:50:51Z","timestamp":1257403851000},"page":"663-669","source":"Crossref","is-referenced-by-count":10,"title":["Membrane and envelope virus proteins co-expressed as lysosome associated membrane protein (LAMP) fused antigens: a potential tool to develop DNA vaccines against flaviviruses"],"prefix":"10.1590","volume":"81","author":[{"given":"Rafael","family":"Dhalia","sequence":"first","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milton","family":"Maciel Jr.","sequence":"additional","affiliation":[{"name":"Johns Hopkins University, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e1bia S.P.","family":"Cruz","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle F.T.","family":"Viana","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana L.","family":"Palma","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"August","sequence":"additional","affiliation":[{"name":"Johns Hopkins University, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto T.A.","family":"Marques Jr.","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz, Brasil; Johns Hopkins University, USA; Johns Hopkins University, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.virol.2004.11.022","article-title":"West Nile premembrane-envelope genetic vaccine encoded as a chimera containing the transmembrane and cytoplasmic domains of a lysosome-associated membrane protein: increased cellular concentration of the transgene product, targeting to the MHC II compartment, and enhanced neutralizing antibody response","volume":"332","author":"ANWAR A ET AL","year":"2005","journal-title":"Virology","ISSN":"https:\/\/id.crossref.org\/issn\/0042-6822","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1365-2567.2004.01823.x","article-title":"DNA vaccine encoding human immunodeficiency virus-1 Gag, targeted to the major histocompatibility complex II compartment by lysosomalassociated membrane protein, elicits enhanced long-term memory response","volume":"112","author":"ARRUDA LB ET AL","year":"2004","journal-title":"Immunology","ISSN":"https:\/\/id.crossref.org\/issn\/0019-2805","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.4049\/jimmunol.177.4.2265","article-title":"Dendritic cell-lysosomal-associated membrane protein (LAMP) and LAMP-1-HIV-1 gag chimeras have distinct cellular trafficking pathways and prime T and B cell responses to a diverse repertoire of epitopes","volume":"177","author":"ARRUDA LB ET AL","year":"2006","journal-title":"J Immunol","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1767","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1749-6632.2001.tb02702.x","article-title":"Current status of flavivirus vaccines","volume":"951","author":"BARRETT AD","year":"2001","journal-title":"Ann N Y Acad Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0077-8923","issn-type":"print"},{"key":"ref5","first-page":"992","article-title":"Arilvax (PowderJect)","volume":"3","author":"BARRETT AD","year":"2002","journal-title":"Curr Opin Investig Drugs"},{"issue":"RR-17","key":"ref6","first-page":"1","article-title":"Yellow fever vaccine","volume":"51","author":"CETRON MS ET AL","year":"2002","journal-title":"Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002. MMWR Recomm Rep"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.virol.2004.02.025","article-title":"Inverted terminal repeat sequences of adeno-associated virus enhance the antibody and CD8(+) responses to a HIV-1 p55Gag\/LAMP DNA vaccine chimera","volume":"323","author":"CHIKHLIKAR P ET AL","year":"2004","journal-title":"Virology","ISSN":"https:\/\/id.crossref.org\/issn\/0042-6822","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1146\/annurev.immunol.15.1.617","article-title":"DNA vaccines","volume":"15","author":"DONNELLY JJ ET AL","year":"1997","journal-title":"Annu Rev Immunol","ISSN":"https:\/\/id.crossref.org\/issn\/0732-0582","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0020-7519(03)00056-0","article-title":"Technical and regulatory hurdles for DNA vaccines","volume":"33","author":"DONNELLY JJ ET AL","year":"2003","journal-title":"Int J Parasitol","ISSN":"https:\/\/id.crossref.org\/issn\/0020-7519","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.4049\/jimmunol.162.2.1150","article-title":"Involvement of MIIC-like late endosomes in B cell receptor-mediated antigenprocessing in murine B cells","volume":"162","author":"DRAKE JR ET AL","year":"1999","journal-title":"J Immunol","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1767","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1083\/jcb.139.3.639","article-title":"Major histocompatibility complex class II compartments in human and mouse B lymphoblasts represent conventional endocytic compartments","volume":"139","author":"KLEIJMEER MJ ET AL","year":"1997","journal-title":"J Cell Biol","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9525","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s11908-996-0005-9","article-title":"Current Assessment of Yellow Fever and Yellow Fever Vaccine","volume":"6","author":"LEFEUVRE A ET AL","year":"2004","journal-title":"Curr Infect Dis Rep"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0065-3527(08)60367-X","article-title":"DNA vaccines: a review","volume":"54","author":"LEWIS PJ","year":"1999","journal-title":"Adv Virus Res","ISSN":"https:\/\/id.crossref.org\/issn\/0065-3527","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1083\/jcb.102.5.1593","article-title":"Lysosomal membrane dynamics: structure and interorganellar movement of a major lysosomal membrane glycoprotein","volume":"102","author":"LIPPINCOTT-SCHWARTZ J","year":"1986","journal-title":"J Cell Biol","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9525","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1046\/j.1365-2796.2003.01140.x","article-title":"DNA vaccines: a review","volume":"253","author":"LIU MA","year":"2003","journal-title":"J Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0954-6820","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1016\/S0264-410X(03)00009-4","article-title":"Dengue 2 PreM-E\/LAMP chimera targeted to the MHC class II compartmentelicits long-lasting neutralizing antibodies","volume":"21","author":"LU Y ET AL","year":"2003","journal-title":"Vaccine","ISSN":"https:\/\/id.crossref.org\/issn\/0264-410X","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.4049\/jimmunol.161.12.6532","article-title":"Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC","volume":"161","author":"MAECKER HT ET AL","year":"1998","journal-title":"J Immunol","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1767","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"37926","DOI":"10.1074\/jbc.M303336200","article-title":"HIV-1 p55Gag encoded in the lysosome-associated membrane protein-1 as a DNA plasmid vaccine chimera is highly expressed, traffics to the major histocompatibility class II compartment, and elicits enhanced immune responses","volume":"278","author":"ET AL","year":"2003","journal-title":"J Biol Chem","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9258","issn-type":"print"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1128\/JVI.76.4.1932-1943.2002","article-title":"Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines","volume":"76","author":"MONATH TP ET AL","year":"2002","journal-title":"J Virol","ISSN":"https:\/\/id.crossref.org\/issn\/0022-538X","issn-type":"print"},{"key":"ref20","first-page":"895","article-title":"Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine","volume":"59","author":"POLAND JD ET AL","year":"1981","journal-title":"Bull World Health Organ","ISSN":"https:\/\/id.crossref.org\/issn\/0042-9686","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0065-3527(03)61012-2","article-title":"DNA vaccines for flaviviruses","volume":"61","author":"PUTNAK R ET AL","year":"2003","journal-title":"Adv Virus Res","ISSN":"https:\/\/id.crossref.org\/issn\/0065-3527","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/S0264-410X(99)00570-8","article-title":"Immunogenicity of dengue virus type 1 DNA vaccines expressing truncated and full length envelope protein","volume":"18","author":"RAVIPRAKASH K ET AL","year":"2000","journal-title":"Vaccine","ISSN":"https:\/\/id.crossref.org\/issn\/0264-410X","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1006\/viro.2001.1136","article-title":"Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF","volume":"290","author":"RAVIPRAKASH K ET AL","year":"2001","journal-title":"Virology","ISSN":"https:\/\/id.crossref.org\/issn\/0042-6822","issn-type":"print"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1096-9071(199810)56:2<159::AID-JMV10>3.0.CO;2-B","article-title":"Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fevervirus strain 17D: a model of human flavivirus infection","volume":"56","author":"REINHARDT B ET AL","year":"1998","journal-title":"J Med Virol","ISSN":"https:\/\/id.crossref.org\/issn\/0146-6615","issn-type":"print"},{"key":"ref25","first-page":"549","article-title":"DNA vaccines: basic mechanism and immune responses (Review)","volume":"4","author":"ROBINSON HL","year":"1999","journal-title":"Int J Mol Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.coi.2004.03.004","article-title":"Towards a cellular definition of CD8+ T-cell memory: the role of CD4+ T-cell help in CD8+ T-cell responses","volume":"16","author":"ROCHA B","year":"2004","journal-title":"Curr Opin Immunol","ISSN":"https:\/\/id.crossref.org\/issn\/0952-7915","issn-type":"print"},{"key":"ref27","first-page":"109","article-title":"Immune modulation in cancer using DNA inoculation-antitumour effect of interleukin-12","volume":"104","author":"SCHULTZ J ET AL","year":"2000","journal-title":"Dev Biol (Basel)"},{"issue":"5465","key":"ref28","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1126\/science.288.5465.522","article-title":"Transport of peptide-MHC class II complexes in developing dendritic cells","volume":"288","author":"TURLEY SJ ET AL","year":"2000","journal-title":"Science","ISSN":"https:\/\/id.crossref.org\/issn\/0036-8075","issn-type":"print"},{"issue":"9276","key":"ref29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(01)05326-0","article-title":"Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases","volume":"358","author":"VASCONCELOS PF ET AL","year":"2001","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.micinf.2006.06.010","article-title":"Development of an effective Japanese encephalitis virus-specific DNA vaccine","volume":"8","author":"WU CJ ET AL","year":"2006","journal-title":"Microbes Infect"}],"container-title":["Anais da Academia Brasileira de Ci\u00eancias"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/aabc\/v81n4\/05.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T11:47:24Z","timestamp":1685188044000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0001-37652009000400005&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0001-37652009000400005"],"URL":"https:\/\/doi.org\/10.1590\/s0001-37652009000400005","relation":{},"ISSN":["0001-3765"],"issn-type":[{"value":"0001-3765","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}